Limits...
Discrepancy between Clinical and Final Pathological Evaluation Findings in Early Gastric Cancer Patients Treated with Endoscopic Submucosal Dissection.

Kim YI, Kim HS, Kook MC, Cho SJ, Lee JY, Kim CG, Ryu KW, Kim YW, Choi IJ - J Gastric Cancer (2016)

Bottom Line: The cases with expanded indications (30.2%) were revealed to be out-of-indication more frequently than the cases with absolute indications (13.8%; P<0.001).Age of >65 years, tumor size of >2 cm, tumor location in the upper-third segment of the stomach, and undifferentiated histological type in pre-endoscopic submucosal resection evaluations were significant risk factors for out-of-indication after endoscopic submucosal resection.The possibility of additional surgery should be emphasized for patients with early gastric cancers that clinically meet the expanded indications.

View Article: PubMed Central - PubMed

Affiliation: Center for Gastric Cancer, National Cancer Center, Goyang, Korea.

ABSTRACT

Purpose: Early gastric cancer cases that are estimated to meet indications for treatment before endoscopic submucosal resection are often revealed to be out-of-indication after the treatment. We investigated the short-term treatment outcomes in patients with early gastric cancer according to the pretreatment clinical endoscopic submucosal resection indications.

Materials and methods: We retrospectively reviewed the medical records of patients with early gastric cancer that met the pretreatment endoscopic submucosal resection indications, from 2004 to 2011. Curative resection rate and proportion of out-of-indication cases were compared according to the pre-endoscopic submucosal resection indications. Pre-endoscopic submucosal resection factors associated with out-of-indication in the final pathological examination were analyzed.

Results: Of 756 cases, 660 had absolute and 96 had expanded pre-endoscopic submucosal resection indications. The curative resection rate was significantly lower in the patients with expanded indications (64.6%) than in those with absolute indications (81.7%; P<0.001). The cases with expanded indications (30.2%) were revealed to be out-of-indication more frequently than the cases with absolute indications (13.8%; P<0.001). Age of >65 years, tumor size of >2 cm, tumor location in the upper-third segment of the stomach, and undifferentiated histological type in pre-endoscopic submucosal resection evaluations were significant risk factors for out-of-indication after endoscopic submucosal resection.

Conclusions: Non-curative resection due to out-of-indication occurred in approximately one-third of the early gastric cancer cases that clinically met the expanded indications before endoscopic submucosal resection. The possibility of additional surgery should be emphasized for patients with early gastric cancers that clinically meet the expanded indications.

No MeSH data available.


Related in: MedlinePlus

Flowchart of the study. EGC = early gastric cancer; ESD = endoscopic submucosal dissection.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4834619&req=5

Figure 1: Flowchart of the study. EGC = early gastric cancer; ESD = endoscopic submucosal dissection.

Mentions: Of the 967 EGC lesions, 756 were included in the final analyses (Fig. 1). These tumors were further classified into the pre-ESD absolute and expanded indication groups on the basis of diagnostic evaluations. EGC lesions met the pre-ESD absolute indications in 660 cases (87.3%) and the pre-ESD expanded indications in 96 cases (12.7%)


Discrepancy between Clinical and Final Pathological Evaluation Findings in Early Gastric Cancer Patients Treated with Endoscopic Submucosal Dissection.

Kim YI, Kim HS, Kook MC, Cho SJ, Lee JY, Kim CG, Ryu KW, Kim YW, Choi IJ - J Gastric Cancer (2016)

Flowchart of the study. EGC = early gastric cancer; ESD = endoscopic submucosal dissection.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4834619&req=5

Figure 1: Flowchart of the study. EGC = early gastric cancer; ESD = endoscopic submucosal dissection.
Mentions: Of the 967 EGC lesions, 756 were included in the final analyses (Fig. 1). These tumors were further classified into the pre-ESD absolute and expanded indication groups on the basis of diagnostic evaluations. EGC lesions met the pre-ESD absolute indications in 660 cases (87.3%) and the pre-ESD expanded indications in 96 cases (12.7%)

Bottom Line: The cases with expanded indications (30.2%) were revealed to be out-of-indication more frequently than the cases with absolute indications (13.8%; P<0.001).Age of >65 years, tumor size of >2 cm, tumor location in the upper-third segment of the stomach, and undifferentiated histological type in pre-endoscopic submucosal resection evaluations were significant risk factors for out-of-indication after endoscopic submucosal resection.The possibility of additional surgery should be emphasized for patients with early gastric cancers that clinically meet the expanded indications.

View Article: PubMed Central - PubMed

Affiliation: Center for Gastric Cancer, National Cancer Center, Goyang, Korea.

ABSTRACT

Purpose: Early gastric cancer cases that are estimated to meet indications for treatment before endoscopic submucosal resection are often revealed to be out-of-indication after the treatment. We investigated the short-term treatment outcomes in patients with early gastric cancer according to the pretreatment clinical endoscopic submucosal resection indications.

Materials and methods: We retrospectively reviewed the medical records of patients with early gastric cancer that met the pretreatment endoscopic submucosal resection indications, from 2004 to 2011. Curative resection rate and proportion of out-of-indication cases were compared according to the pre-endoscopic submucosal resection indications. Pre-endoscopic submucosal resection factors associated with out-of-indication in the final pathological examination were analyzed.

Results: Of 756 cases, 660 had absolute and 96 had expanded pre-endoscopic submucosal resection indications. The curative resection rate was significantly lower in the patients with expanded indications (64.6%) than in those with absolute indications (81.7%; P<0.001). The cases with expanded indications (30.2%) were revealed to be out-of-indication more frequently than the cases with absolute indications (13.8%; P<0.001). Age of >65 years, tumor size of >2 cm, tumor location in the upper-third segment of the stomach, and undifferentiated histological type in pre-endoscopic submucosal resection evaluations were significant risk factors for out-of-indication after endoscopic submucosal resection.

Conclusions: Non-curative resection due to out-of-indication occurred in approximately one-third of the early gastric cancer cases that clinically met the expanded indications before endoscopic submucosal resection. The possibility of additional surgery should be emphasized for patients with early gastric cancers that clinically meet the expanded indications.

No MeSH data available.


Related in: MedlinePlus